Very positive Clinical Phase I/IIa results for Calcipotriol AKVANO formulation for the treatment of Psoriasis 13 September 2013
Helsinn Group and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting 16 May 2013
NEWSOur new plant for CHO based mAb or Recombinant Protein manufacturing is ready for the qualification phase 19 February 2013
Cerbios Pharma and XSpray agree to establish a long-term partnership on the use of XSpray’s RightSizeTM technology 31 August 2012
Lipidor and Cerbios-Pharma have signed an agreement for the co- development of an innovative topical delivery system 13 June 2012
Linkedin